Beyond addressing supply issues, the approach could potentially reduce costs for these expensive medications, which can run patients thousands of dollars annually without insurance coverage
Your provider can review your complete surgical and medical history to confirm GLP-1 is appropriate for your situation and may adjust starting doses or monitoring schedules based on your individual recovery timeline
Based on Phase 3 timelines, a realistic window for FDA approval is 2026 to 2027
Li C, Tang Z, Zhang W, Ye Z, Liu F
Yet over the years our weight continues to increase, and eventually we get to a point where we feel like its too late to change
a 30 mg vial makes that same dose just 25 units and leaves room to climb the ladder